Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-10-18

Clinical Trial Update: Amantadine for Treatment of Symptoms of the Post-traumatic Confusional State [Phase 4]

View source ↗

Summary

Phase 4 trial update assessing amantadine for symptoms of post-traumatic confusional state in traumatic brain injury patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • amantadine (amantadine)

Snippet

Sponsor: Methodist Rehabilitation Center | Conditions: Traumatic Brain Injury, Posttraumatic Confusional State | Phase 4 | Status: COMPLETED